BridgeBio Pharma (BBIO) PT Lowered to $19 at JPMorgan
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.59 --0%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 31
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 31
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on BridgeBio Pharma (NASDAQ: BBIO) to $19.00 (from $20.00) while maintaining a Overweight rating.
You May Also Be Interested In
- BridgeBio Pharma (BBIO) PT Raised to $110 at Mizuho
- Yantai China Pet Foods Co Ltd (002891:CH) PT Lowered to RMB34 at Macquarie
- Palo Alto Networks (PANW) PT Raised to $430 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
